Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum

Cell Calcium. 2007 Jul;42(1):83-90. doi: 10.1016/j.ceca.2006.11.009. Epub 2007 Jan 3.

Abstract

We have identified a novel endoplasmic reticulum (ER)-resident protein, named "calumin", which is expressed in various tissues. This protein has a molecular mass of approximately 60 kDa and is composed of an ER-luminal domain rich in acidic residues, a single transmembrane segment, and a large cytoplasmic domain. Biochemical experiments demonstrated that the amino-terminal luminal domain is capable of binding Ca2+ with a high capacity and moderate affinity. In embryonic fibroblasts derived from calumin-knockout mice exhibiting embryonic and neonatal lethality, fluorometric Ca2+ imaging detected insufficient Ca2+ contents in intracellular stores and attenuated store-operated Ca2+ entry. Moreover, the mutant fibroblasts were highly sensitive to cell death induced by ER stress. These observations suggest that calumin plays an essential role in ER Ca2+ handling and is also implicated in signaling from the ER, which is closely associated with cell-fate decision.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Calcium Signaling / physiology
  • Calcium-Binding Proteins / isolation & purification
  • Calcium-Binding Proteins / physiology*
  • Cloning, Molecular
  • Endoplasmic Reticulum / chemistry*
  • Membrane Proteins / isolation & purification
  • Membrane Proteins / physiology*
  • Mice
  • Mice, Knockout
  • Molecular Weight
  • Oxidative Stress / physiology
  • Rats
  • Thapsigargin / pharmacology
  • Tunicamycin / pharmacology

Substances

  • Calcium-Binding Proteins
  • Membrane Proteins
  • Tunicamycin
  • Thapsigargin
  • Calcium